Kadimastem Ltd. engages in developing cell therapy in the field of regenerative medicine. It develops a platform for the development and production of embryonic stem cells and various engineered pluripotent stem cells for the purpose of developing cell drugs as off-the-shelf products in the field of regenerative medicine. The company was founded by Yossi Ben Yosef and Michel Revel on October 6, 2008 and is headquartered in Ness Ziona, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
11
Frequently Asked Questions
What is Market Cap of Kadimastem Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kadimastem Ltd. market cap is $23.53M.
What is the 52-week high for Kadimastem Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kadimastem Ltd. 52 week high is $5.10 as of September 06, 2025.
What is the 52-week low for Kadimastem Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kadimastem Ltd. 52 week low is $0.6404 as of September 06, 2025.
What is Kadimastem Ltd. stock price today?
Kadimastem Ltd. stock price today is $5.06.
What was Kadimastem Ltd. stock price yesterday?
Kadimastem Ltd. stock price yesterday was $5.10.
What is the PE ratio of Kadimastem Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kadimastem Ltd.’s P/E ratio is -1.30.
What is the Price-to-Book ratio of Kadimastem Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kadimastem Ltd. P/B ratio is -1.5111.
What is the 50-day moving average of Kadimastem Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kadimastem Ltd. 50-day moving average is $5.06.